Atlas Trials

Value of CD26 Positive Leukemic Stem Cell in Myeloproliferative Neoplasm

Clinical trial NCT04312607 · UNKNOWN

Trial details

NCT number
NCT04312607
Sponsor
Safaa AA Khaled
Status
UNKNOWN
Study type
OBSERVATIONAL
Myeloproliferative Neoplasm
Start date
2020-08-01
Primary completion
2021-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.